News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...
In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...
The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...
What to Expect on MSN3d
Should Pregnant Women Still Get the COVID-19 Vaccine?Here’s everything parents should know about the COVID-19 vaccines for pregnant women, including why it's still an important way to protect yourself and your baby. Should I get t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback